Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: A literature review from January 2002 to March 2013

Journal of Infection in Developing Countries

Volumn 8, Issue 9, 2014, Pages 1137-1147

  Areeshi, Mohammed Yahya ^a   Bisht, Shekhar Chandra ^b   Mandal, Raju Kumar ^a   Haque, Shafiul ^a,c  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b H N B GARHWAL UNIVERSITY   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Drug resistance; GCC; Gulf countries; MDR TB; Mycobacterium tuberculosis; TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; AUTOMATED LINEAR MODELING; HUMAN; INFORMATION PROCESSING; KUWAIT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OMAN; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; SAUDI ARABIA; TUBERCULOSIS; UNITED ARAB EMIRATES; ANTIBIOTIC RESISTANCE; ASIA; DRUG EFFECTS; ISOLATION AND PURIFICATION;

ANTITUBERCULAR AGENTS; ARABIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULOSIS;

EID: 84907016085     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4053     Document Type: Article

References (48)

1. World Health Organization (2012) Global Tuberculosis Control Report. Geneva: World Health Organization. Available: http://www.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf. Accessed 5 April 2013.
2. Raviglione MC, Marais B, Floyd K, Lonnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S, Chakaya J, Weyer K, Cole S, Kaufmann SH, Zumla A (2012) Scaling up interventions to achieve global tuberculosis control: progress and new 292 developments. Lancet 79: 1902-1913.
3. Dalton T, Cegielski P, Akksilp S, Asencios L, Caoili JC, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H (2012) Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet 380 Suppl 9851: 1406-1417.
4. Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z (2013) Epidemiology of Anti-tuberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey. Antimicrob Agents Chemother 57 Suppl 5: 2161-2166.
5. Zignol M, van-Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M (2012) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Org 90: 111-119D.
6. PressTV (2011) Jordan, Morocco to join [P] GCC. Available: http://www.presstv.ir/detail/179363.html. Accessed 5 May 2013.
7. Al-Sharif A (2011) Gulf bloc to consider Jordan, Morocco membership. Available at http://news.xinhuanet.com/english2010/world/2011-05/11/c_13868474.htm. Accessed 27 April 2013.
8. Roberts L (2007) Yemen to join GCC by 2015. Arabian Business. Available: http://www.arabianbusiness.com/yemen-join-gcc-by-2015-57086.html. Accessed 27 April 2013.
9. World Health Organization (2011) Global Tuberculosis Control Report. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf. Accessed 7 May 2013
10. Yezli S, Memish ZA (2012) Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother 24: 1-5.
11. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR (1993) Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 328 Suppl 8: 527-532.
12. Tupasi T, Gupta R, Quelapio MaID, Orillaza RB, Mira NR, Mangubat NV, Arnisto VBN, Macalintal L, Arabit M, Lagahid JY, Espinal M, Floyd K (2006) Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines. PLoS Med 3: e352.
13. Khoja TAM (2010) Rules and regulations for medical examination of expatriates recruited for work in the GCC states. Riyadh: Executive Board of the Health Ministers' Council for Cooperation Council States Available: http://sgh.org.sa/Portals/0/PDF/Books/RulesAndRegulationForMedical.pdf. Accessed 10 May 2013.
14. Ahmad S, Fares E, Araj GF, Chugh TD, Mustafa AS (2002) Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int J Tuberc Lung Dis 6: 920-926.
15. World Health Organization (2010) Country cooperation strategy at a glance. Geneva: World Health Organization. Available at: http://www.who.int/countryfocus/cooperation_strategy/ccsbrief_omn_en.pdf. Accessed 9 May 2013.
16. Alrajhi AA, Al-Barrak AM (2002) Mycobacterium tuberculosis susceptibility in Saudi Arabia. Saudi Med J 23: 1227-1231.
17. Alzeer AH (2009) Respiratory tract infection during Hajj. Ann Thorac Med 4: 50-53.
18. Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM (2002) Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J 23: 305-310.
19. Al-Hajoj S, Alrabiah F (2004) Role of tuberculosis laboratories in Saudi Arabia. A call to implement standardized procedures. Saudi Med J 25: 1545-1548.
20. Nathanson E, Lambregts-Vanweezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12: 1389-1397.
21. Resch S, Salomon J, Murray M, Weinstein M (2006) Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 3: e241.
22. D'Costa V, King C, Kalan L, Morar M, Sung W, Schwartz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD (2011) Antibiotic resistance is ancient. Nature 477 Suppl 7365: 457-461.
23. Al-Khal AL, Bener A, Enarson DA (2005) Tuberculosis among garment workers in an Arabian developing country: State of Qatar. Arch Environ Occup Health 60: 295-298.
24. Khan FY (2009) Clinical pattern of tuberculous adenitis in Qatar: experience with 35 patients. Scand J Infect Dis 41 Suppl 2: 128-134.
25. Khan FY, Al-Muzrakchi AM, Elbedawi MM, Al-Muzrakchi AA, Al-Tabeb A (2012) Peritoneal tuberculosis in Qatar: a five-year hospital-based study from 2005 to 2009. Travel Med Infect Dis 10 Suppl 1: 25-31.
26. Al-Maniri A, Al-Rawas O, Al-Tuhami H, Eriksson B, Diwan VK (2007) Towards the elimination of tuberculosis in a developing country: 25 years of tuberculosis control in Oman. Int J Tuberc Lung Dis 11: 175-180.
27. Mohammadi A, Nassor ZS, Behlim T, Mohammadi E, Govindarajan R, Al-Maniri A. Smego Jr RA (2008) Epidemiological and cost analysis of multidrug-resistant tuberculosis in Oman. East Mediterr Health J 14 Suppl 6: 1240-1245.
28. Al-Maniri A, Singh JP, Al-Rawas O, Al-Busaidi S, Al-Balushi L, Ahmed I, Al-Mahruqi S, Haile M, Diwan VK, Hoffner S (2010) A snapshot of the biodiversity and clustering of Mycobacterium tuberculosis in Oman using spoligotyping. Int J Tuberc Lung Dis 14: 994-1000.
29. Mokaddas E, Ahmad S, Abal AT (2002) Molecular fingerprinting of isoniazid-resistant Mycobacterium tuberculosis isolates from Chest Disease Hospital in Kuwait. Microbiol Immunol 46: 767-771.
30. Ahmad S, Mokaddas E (2005) The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 26: 205-212.
31. Ahmad S, Jaber AA, Mokaddas E (2007) Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinb) 87: 123-129.
32. Al-Mutairi NM, Ahmad S, Mokaddas E (2008) Performance of the genotype MTBDR assay for molecular detection of multidrug-resistant strains of Mycobacterium tuberculosis. Ann Saudi Med 28: 203-206.
33. Mokaddas E, Ahmad S, Samir I (2008) Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005. Int J Tuberc Lung Dis 12: 319-325.
34. Jaber AA, Ahmad S, Mokaddas E (2009) Minor contribution of mutations at iniA codon 501 and embC-embAintergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Ann Clin Microbiol Antimicrob 8: 2.
35. Al-Mutairi NM, Ahmad S, Mokaddas E (2011) Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis 15: 110-115.
36. Ahmad S, Al-Mutairi N, Mokaddas E (2012) Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait. Indian J Med Res 135: 756-762.
37. Ahmad S, Fares E (2005) Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. Med Princ Pract 14: 16-21.
38. Ahmad S, Itani LY, Fares E, Araj GF (2008) Varying prevalence of embB codon 306 mutations in ethambutol-resistant clinical Mycobacterium tuberculosis isolates from Beirut and Dubai. J Chemother 20: 285-287.
39. Al-Zarouni M, Dash N, Al-Ali M, Al-Shehhi F, Panigrahi D (2010) Tuberculosis and MDR-TB in the northern emirates of United Arab Emirates: a 5-year study. Southeast Asian J Trop Med Public Health 41: 163-168.
40. Saif Alfaresi M, Hag-Ali M (2010) Susceptibility Pattern and Epidemiology of Mycobacterium tuberculosis in United Emirati Hospital. Open Microbiol J 4: 1-4.
41. Kordy FN, Al-Thawadi S, Alrajhi AA (2004) Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 8: 1007-1011.
42. Al-Tawfiq JA, Al-Muraikhy AA, Abed MS (2005) Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. Chest 128: 3229-3232.
43. Al-Anazi KA, Al-Jasser A, Evans DA (2007) Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Ann Clin Microbiol Antimicrob 6: 16.
44. Al-Hajoj S, Zozio AT, Al-Rabiah F, Mohammad V, Al-Nasser M, Sola C, Rastogi N (2007) First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia. J Clin Microbiol 45: 2467-2473.
45. Al-Shehri AM, Al-Ghamdi SM, Khalil A, Al-Amoudi, A, Baslaim A, Mamoun I (2007) Multi-drug-resistant tuberculosis in a patient presenting with bilateral gluteal abscesses and right leg swelling with end-stage renal disease. Saudi J Kidney Dis Transpl 18: 603-608.
46. Al-Qtabi F, Hazmi MMEI (2010) Extra-pulmonary tuberclorosis in Saudi Arabia. Indian J Pathol Microbiol 53: 227-231.
47. Asaad AM, Alqahtani JM (2012) Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in Southwestern Saudi Arabia. J Infect Public Health 5: 281-285.
48. Varghese B, Hillemann A, Wijayanti DR, Shoukri M, Al-Rabiah F, Al-Omari R, Al-Hajoj S (2012) New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia. Infect Genet Evol 12: 549-556.